IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING.
SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN.
LETTER OF INVESTMENT INTENT
414 North Orleans Street, Suite 502
Chicago, Illinois 60610
The undersigned (the “ Subscriber”) hereby tenders this subscription for the purchase of securities (the “
Securities”) of Cytocore, Inc. (the “ Company”), consisting of units ( “ Units”). The Units are offered by the
Company (the “ Offering”) through Bathgate Capital Partners, LLC (the “Finder”). The Units and the terms of
the Offering are described in the Purchase Agreement delivered contemporaneously with this Subscription
Agreement (the “ Purchase Agreement”). Subscriber understands that a subscription for the Securities may be
rejected for any reason and that, in the event that this subscription is rejected, the funds delivered herewith will be
promptly returned, without interest thereon or deduction therefrom. By execution below, the Subscriber
acknowledges that the Company is relying upon the accuracy and completeness of the representations contained
herein in complying with their obligations under applicable securities laws.
ARTICLE 1 — SUBSCRIPTION AND DESCRIPTION OF SECURITIES
1.1 Subscription for Units
The Subscriber hereby confirms its subscription for and offers to purchase the Securities from the Company,
on and subject to the terms and conditions set out in this Subscription Agreement, and hereby tenders the full
Subscription Amount in cash or check payable to “Cytocore, Inc. Escrow Account” in the amount subscribed
for. Investors may also wire funds to the escrow account as set forth below:
Front Range Bank
7600 S. Alton Way, Building B
Centennial, CO 801